%0 Journal Article %1 Koelble2000 %A Kölble, K. %A Barthel, B. %A Ullrich, O. %A Pidde, H. %A Döhring, C. %A Rüschoff, J. %A Schlag, P. M. %A Dietel, M. %D 2000 %J Verh Dtsch Ges Pathol %K Cadherins,_genetics Colorectal_Neoplasms,_genetics/pathology Cytoskeletal_Proteins,_genetics DNA,_Neoplasm,_genetics Exons Genes,_APC Genetic_Markers Humans Microsatellite_Repeats,_genetics Proto-Oncogene_Proteins,_genetics/metabolism Retrospective_Studies Trans-Activators Wnt_Proteins Zebrafish_Proteins beta_Catenin %P 182-186 %T beta-Catenine as a genomic target of high-grade microsatellite instability in colorectal cancer %V 84 %X AIMS: Various inherited and acquired alterations affecting the genes and gene products of the WNT pathway appear to be involved in the different molecular routes leading to colorectal cancer (CRC). This study was initiated to investigate the prevalence of somatic mutations in the beta-catenin gene (CTNNB1) and the associated pathology in CRC with defective DNA mismatch repair. METHODS: Paraffin and/or frozen sections of 33 primary CRC (including any liver and lymph node metastases present) with high-grade microsatellite instability (MSI-H; i.e. with > or = 5 unstable microsatellite markers of 10 tested) were polytopically fractionated by microdissection. Genomic and c-DNA samples were sequenced across exons 2-4 of CTNNB1 and the expression patterns of beta-catenin (beta-C) analyzed by immunohistology and Western blotting. RESULTS: Seven somatic mutations affecting phosphorylation sites of exon 3 (2 deletions also encompassing parts of either intron 2 or exon 4 delta X2/3 bzw. delta X3/4 and 5 missense mutations 2 x T41A, 2 x S45F, S45P) were identified. Two mutations (delta X3/4 and S45F) were concordantly present in CRC primaries and their respective metastases whereas the S45P mutation was restricted to a hepatic metastasis. In the delta X2/3 CRC primary only a shortened 66 kD CTNNB1 gene product was present while its associated liver metastasis showed a total loss of beta-C expression. CONCLUSIONS: Both exon 3 and the entire locus coding for beta-C are somatically altered in approximately 20% of CRC with MSI-H at different stages of tumor progression. Thus CTNNB1 appears to be a genomic target for complex oncogenic mutations and deletional processes in a substantial fraction of this molecular subset of CRC.

@article{Koelble2000, abstract = {AIMS: Various inherited and acquired alterations affecting the genes and gene products of the WNT pathway appear to be involved in the different molecular routes leading to colorectal cancer (CRC). This study was initiated to investigate the prevalence of somatic mutations in the beta-catenin gene (CTNNB1) and the associated pathology in CRC with defective DNA mismatch repair. METHODS: Paraffin and/or frozen sections of 33 primary CRC (including any liver and lymph node metastases present) with high-grade microsatellite instability (MSI-H; i.e. with > or = 5 unstable microsatellite markers of 10 tested) were polytopically fractionated by microdissection. Genomic and c-DNA samples were sequenced across exons 2-4 of CTNNB1 and the expression patterns of beta-catenin (beta-C) analyzed by immunohistology and Western blotting. RESULTS: Seven somatic mutations affecting phosphorylation sites of exon 3 (2 deletions also encompassing parts of either intron 2 or exon 4 [delta X2/3 bzw. delta X3/4] and 5 missense mutations [2 x T41A, 2 x S45F, S45P]) were identified. Two mutations (delta X3/4 and S45F) were concordantly present in CRC primaries and their respective metastases whereas the S45P mutation was restricted to a hepatic metastasis. In the delta X2/3 CRC primary only a shortened 66 kD CTNNB1 gene product was present while its associated liver metastasis showed a total loss of beta-C expression. CONCLUSIONS: Both exon 3 and the entire locus coding for beta-C are somatically altered in approximately 20% of CRC with MSI-H at different stages of tumor progression. Thus CTNNB1 appears to be a genomic target for complex oncogenic mutations and deletional processes in a substantial fraction of this molecular subset of CRC.}, added-at = {2010-01-26T20:35:53.000+0100}, author = {K{\"{o}}lble, K. and Barthel, B. and Ullrich, O. and Pidde, H. and D{\"{o}}hring, C. and R{\"{u}}schoff, J. and Schlag, P. M. and Dietel, M.}, biburl = {https://www.bibsonomy.org/bibtex/24e7de6e5b63e1ff704b6416dd171730a/denilw}, institution = {Institut f{\"{u}}r Pathologie, Universit{\"{a}}tsklinikum Charit{\'{e}}, Humboldt-Universit{\"{a}}t, Berlin.}, interhash = {3bbbd132e7caf4e6d5bda046b7ab394f}, intrahash = {4e7de6e5b63e1ff704b6416dd171730a}, journal = {Verh Dtsch Ges Pathol}, keywords = {Cadherins,_genetics Colorectal_Neoplasms,_genetics/pathology Cytoskeletal_Proteins,_genetics DNA,_Neoplasm,_genetics Exons Genes,_APC Genetic_Markers Humans Microsatellite_Repeats,_genetics Proto-Oncogene_Proteins,_genetics/metabolism Retrospective_Studies Trans-Activators Wnt_Proteins Zebrafish_Proteins beta_Catenin}, owner = {denilw}, pages = {182-186}, pmid = {11217439}, timestamp = {2010-01-26T20:36:00.000+0100}, title = {[beta-Catenine as a genomic target of high-grade microsatellite instability in colorectal cancer]}, volume = 84, year = 2000 }